Custom synthesis services

Product Description

Midas Pharma Polska Sp. z.o.o. can deliver one or all building blocks along your synthetic pathway including biocatalytic steps up to the final api. Offers: APIs, high-potency APIs (HAPIs), early and late stage/advanced intermediates (IMs). It includes process development and optimization for APIs and AMs, up-scaling, process validation, development and validation of analytical methods, synthesis of impurities, reference standards, etc.

Midas Pharma Polska Sp. z.o.o.

  • PL
  • 2015
    On CPhI since
Contract Service
Specifications
  • Selling Points
    Experienced Technicians; Reputation
  • Supplied from
    Poland

Midas Pharma Polska Sp. z.o.o.

  • PL
  • 2015
    On CPhI since
Contract Service

More Products from Midas Pharma Polska Sp. z.o.o.

  • Finished product development services

    Product Finished product development services

    NEWS: Hot Melt Extruction is the newest technology now available at Midas Pharma.


    Midas Pharma Polska Sp. z.o.o. provides a complete range of services for developing and manufacturing finished drug products, and we have expertise and experience to overcome challenging galenical or analytical hurdles. It includes modular development support, customizing drug product development strategies, selecting suitable development partners, project management, assessing, improving and implementing manufacturing processes and analytical methods, onsite supervision of critical development activities, etc.



  • Finished product manufacturing services

    Product Finished product manufacturing services

    Midas Pharma Polska Sp. z.o.o. offers a complete package - from API sourcing and technology transfer to variation filing - or just the modular services you require. It includes identification and qualification of suitable contract manufacturer, technology transfer and customizations of equipment, dossier and product characteristics, etc.
  • Biotechnology services

    Product Biotechnology services

    Midas Pharma Polska Sp. z.o.o. offers biosimilars for step-in licensing (pre-developed products) or customised development of selected biologicals, as well as state-of-the art GMP production (microbial and mammalian cells) and fill and finish for biopharmaceuticals.The products of the biotech services include: growth hormones, immunomodulators, monoclonal antibodies, (anti) coagulation factors, antibody drug conjugates, customised enzymes for chemical synthesis. Midas is able to provide full range of expertise (protein biochemistry, molecular genetics, cell biology) for recombinant protein development - from gene to commercial production of biopharmaceuticals. The biotech services cover: DSP — purification, virus depletion, protein formulation (stabilization), GMP production, fill and finish, biosimilarity testing (full characterization of the reference product), etc.euro


  • Business development & licensing services

    Product Business development & licensing services

    HOT DOSSIERS: Atorvastatin + Ezetimibe tabs, Lenalidomide caps, Levodropropizine syrup

    Midas Pharma Polska Sp. z.o.o. offers company's Own as well as Third Party Dossiers, co-development & contract development

    BD&L services include commercialization strategy, promotion, search strategy and scouting, shortlisting and feasibility checking, negotiation, transaction support, etc.

  • Intellectual property services

    Product Intellectual property services

    Midas Pharma Polska Sp. z.o.o. offers diverse services related to pharmaceutical drug products and the active drug substances (APIs) therein, as well as finished dosage forms (FDFs). It includes white spot analysis, product clearance, FTO-analysis & development support, portfolio & innovation management, prosecution & opposition, etc.
  • Quality management services

    Product Quality management services

    Midas Pharma Polska Sp. z.o.o. provides support and services to ensure high product quality and compliance with current valid guidelines and regulations for products used in the pharmaceutical industry - such as APIs, intermediates, excipients, bulk products and finished dosage forms. Midas Auditing Services conducts on-site assessments of manufacturing facilities, conducts follow-up activities, offers support, for example GAP analysis and mock inspections, and ensures continuous improvement of GMP compliance.


  • Regulatory affairs services

    Product Regulatory affairs services

    Midas Pharma Polska Sp. z.o.o. offers regulatory support for human medicinal products, veterinary medicinal products and herbal medicinal products in Europe. This includes drug substance services: development of ASMF/EDMF and US-DMF, CEP applications and life cycle Management) and drug product services: product development/regulatory strategies, pre-submission and/or scientific advice procedures, dossier evaluation and gap analyses, writing chemical-pharmaceutical documentation (CMC), compiling pharmacological-toxicological and clinical documentation, writing quality overall summaries (pharmaceutical-chemical expert reports), etc.
  • Active Pharmaceutical Ingredients & Intermediates

    Product Active Pharmaceutical Ingredients & Intermediates

    API & IM businesses are belonging to the core areas of Midas Pharma Polska Sp. z o.o. activities. Besides the Third Party products we offer Midas' own APIs like: Warfarin Sodium (CEP), Ketoprofen (CEP in progress), Doxapram HCl, Doxazosin Maleate, Trospium Chloride, Amfepramone  HCl  and IMs like: 5-ALA (5-aminolevulinic acid), R3Q (R-3-Quinuclidinol),  

Recommended products